
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6168314
[patent_doc_number] => 20110174623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'Concentration and Purification of Analytes Using Electric Fields'
[patent_app_type] => utility
[patent_app_number] => 13/078551
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12870
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0174/20110174623.pdf
[firstpage_image] =>[orig_patent_app_number] => 13078551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078551 | Concentration and Purification of Analytes Using Electric Fields | Mar 31, 2011 | Abandoned |
Array
(
[id] => 7662296
[patent_doc_number] => 20110311565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Phage Constructs, Sequences and Antigenic Compositions for Immunocontraception of Animals'
[patent_app_type] => utility
[patent_app_number] => 13/069006
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12405
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311565.pdf
[firstpage_image] =>[orig_patent_app_number] => 13069006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/069006 | Phage constructs, sequences and antigenic compositions for immunocontraception of animals | Mar 21, 2011 | Issued |
Array
(
[id] => 6188914
[patent_doc_number] => 20110171720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'SINGLE-DOMAIN BRAIN-TARGETING ANTIBODY FRAGMENTS DERIVED FROM LLAMA ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/052441
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15162
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171720.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052441 | Single domain brain-targeting antibody fragments derived from llama antibodies | Mar 20, 2011 | Issued |
Array
(
[id] => 10000380
[patent_doc_number] => 09044454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Regulation of microvasculature occlusion'
[patent_app_type] => utility
[patent_app_number] => 13/045265
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10070
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045265
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/045265 | Regulation of microvasculature occlusion | Mar 9, 2011 | Issued |
Array
(
[id] => 7573156
[patent_doc_number] => 20110268812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Cosmetic or dermatological composition comprising the combination of honey and a peptide'
[patent_app_type] => utility
[patent_app_number] => 12/932449
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3392
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268812.pdf
[firstpage_image] =>[orig_patent_app_number] => 12932449
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/932449 | Cosmetic or dermatological composition comprising the combination of honey and a peptide | Feb 24, 2011 | Abandoned |
Array
(
[id] => 10142254
[patent_doc_number] => 09175053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Chemical preparation of ubiquitin thioesters and modifications thereof'
[patent_app_type] => utility
[patent_app_number] => 13/578014
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12793
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578014
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578014 | Chemical preparation of ubiquitin thioesters and modifications thereof | Feb 8, 2011 | Issued |
Array
(
[id] => 6002695
[patent_doc_number] => 20110118140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/019142
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 33349
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118140.pdf
[firstpage_image] =>[orig_patent_app_number] => 13019142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/019142 | METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES | Jan 31, 2011 | Abandoned |
Array
(
[id] => 5936007
[patent_doc_number] => 20110212114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/016576
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22935
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212114.pdf
[firstpage_image] =>[orig_patent_app_number] => 13016576
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/016576 | Method for making targeted therapeutic agents | Jan 27, 2011 | Issued |
Array
(
[id] => 6101587
[patent_doc_number] => 20110165079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'PEPTIDE FOR TRANSMIGRATION ACROSS BLOOD BRAIN BARRIER AND DELIVERY SYSTEMS COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/979804
[patent_app_country] => US
[patent_app_date] => 2010-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5731
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12979804
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/979804 | Peptide for transmigration across blood brain barrier and delivery systems comprising the same | Dec 27, 2010 | Issued |
Array
(
[id] => 6083532
[patent_doc_number] => 20110143993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'ENDOTHELIAL BASEMENT MEMBRANE TARGETING PEPTIDE LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/969345
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20647
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20110143993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12969345
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/969345 | ENDOTHELIAL BASEMENT MEMBRANE TARGETING PEPTIDE LIGANDS | Dec 14, 2010 | Abandoned |
Array
(
[id] => 5968984
[patent_doc_number] => 20110150844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR CONTROLLING PROLIFERATION AND DIFFERENTIATION OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/966612
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19920
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966612 | Compositions and methods for controlling proliferation and differentiation of cells | Dec 12, 2010 | Issued |
Array
(
[id] => 6212296
[patent_doc_number] => 20110135596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'FUSION PROTEIN COMPRISING UBIQUITIN OR UBIQUITIN-LIKE PROTEIN, MEMBRANE TRANSLOCATION SEQUENCE AND BIOLOGICALLY ACTIVE MOLECULE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/959965
[patent_app_country] => US
[patent_app_date] => 2010-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6683
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12959965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/959965 | FUSION PROTEIN COMPRISING UBIQUITIN OR UBIQUITIN-LIKE PROTEIN, MEMBRANE TRANSLOCATION SEQUENCE AND BIOLOGICALLY ACTIVE MOLECULE AND USE THEREOF | Dec 2, 2010 | Abandoned |
Array
(
[id] => 8533365
[patent_doc_number] => 08309520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Fully synthetic albumin analog'
[patent_app_type] => utility
[patent_app_number] => 12/952629
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6232
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952629 | Fully synthetic albumin analog | Nov 22, 2010 | Issued |
Array
(
[id] => 10148130
[patent_doc_number] => 09180395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Porous thin films'
[patent_app_type] => utility
[patent_app_number] => 13/508984
[patent_app_country] => US
[patent_app_date] => 2010-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 8210
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508984 | Porous thin films | Nov 19, 2010 | Issued |
Array
(
[id] => 8822136
[patent_doc_number] => 20130123181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'Factor VIII T Cell Epitope Variants Having Reduced Immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 13/509508
[patent_app_country] => US
[patent_app_date] => 2010-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 40733
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509508 | Factor VIII T Cell Epitope Variants Having Reduced Immunogenicity | Nov 14, 2010 | Abandoned |
Array
(
[id] => 8815137
[patent_doc_number] => 20130116182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Factor VIII B Cell Epitope Variants Having Reduced Immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 13/509506
[patent_app_country] => US
[patent_app_date] => 2010-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 40737
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509506
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509506 | Factor VIII B Cell Epitope Variants Having Reduced Immunogenicity | Nov 14, 2010 | Abandoned |
Array
(
[id] => 5936870
[patent_doc_number] => 20110212541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/944345
[patent_app_country] => US
[patent_app_date] => 2010-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 28024
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212541.pdf
[firstpage_image] =>[orig_patent_app_number] => 12944345
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/944345 | COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS | Nov 10, 2010 | Abandoned |
Array
(
[id] => 5944777
[patent_doc_number] => 20110105397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'METHOD FOR TREATING HEART FAILURE WITH STRESSCOPIN-LIKE PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/940019
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 33592
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12940019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/940019 | METHOD FOR TREATING HEART FAILURE WITH STRESSCOPIN-LIKE PEPTIDES | Nov 3, 2010 | Abandoned |
Array
(
[id] => 6215708
[patent_doc_number] => 20110137406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'BIOACTIVE STENTS FOR TYPE II DIABETICS AND METHODS FOR USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/912440
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22570
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20110137406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912440 | BIOACTIVE STENTS FOR TYPE II DIABETICS AND METHODS FOR USE THEREOF | Oct 25, 2010 | Abandoned |
Array
(
[id] => 7550846
[patent_doc_number] => 08063179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895921
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10327
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895921 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |